Related Experiment Video

Updated: May 24, 2025

Author Spotlight: In Vitro Co-Culture Model for Studying Microglia-Neuronal Interactions in Disease Conditions
08:47

Author Spotlight: In Vitro Co-Culture Model for Studying Microglia-Neuronal Interactions in Disease Conditions

Published on: July 26, 2024

1.8K

Pathogenesis and therapeutic applications of microglia receptors in Alzheimer's disease

Jiao Fu1,2, RuoXuan Wang1,2, JiHui He1,2

  • 1Institute of Regenerative and Translational Medicine, Tianyou Hospital, Wuhan University of Science and Technology, Wuhan, China.

Frontiers in Immunology
|March 3, 2025
PubMed

Insights

Microglia receptors are key to brain immune responses and neurodegenerative diseases like Alzheimer's. Targeting these receptors offers potential for new diagnostics and treatments for brain disorders.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are the central nervous system's immune cells, constantly surveying the brain environment.
  • They perform essential functions like clearing cellular debris and misfolded proteins to maintain homeostasis.
  • Dysfunctional microglia contribute to neuroinflammation and neurotoxicity, particularly in neurodegenerative diseases.

Purpose of the Study:

  • To review the role of microglia-expressed receptors in Alzheimer's disease pathogenesis and treatment.
  • To highlight the complexities of targeting microglia for therapeutic interventions in neurodegenerative disorders.
  • To inform the discovery of novel biomarkers and innovative therapeutics.

Main Methods:

  • Literature review focusing on microglia receptors and their functions.
  • Analysis of the role of microglia in Alzheimer's disease.
  • Exploration of therapeutic strategies targeting microglia.

Main Results:

  • Microglia receptors are crucial for sensing environmental cues and regulating microglial function.
  • Microglia play a dual role in neurodegeneration, with both protective and detrimental functions.
  • Targeting microglia presents challenges due to their complex roles in the brain.

Conclusions:

  • Microglia receptors are critical mediators in neuroinflammation and neurodegeneration.
  • Understanding microglia-receptor interactions is vital for developing effective Alzheimer's disease therapies.
  • Further research into microglia modulation holds promise for treating neurodegenerative conditions.
Keywords:
Alzheimer’s diseaseheterogeneitymicrogliamicroglia receptorneuroinflammation

More Related Videos

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.3K
Microglia as a Surrogate Biosensor to Determine Nanoparticle Neurotoxicity08:37

Microglia as a Surrogate Biosensor to Determine Nanoparticle Neurotoxicity

Published on: October 25, 2016

6.9K

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
145
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
418
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
76.9K